| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |